Safety of same-day endoscopic ultrasound and endoscopic retrograde cholangiopancreatography under conscious sedation

Table 1 Patient demographics, indications, and procedure completion rates n (%)

	Tandem (group A) (n = 54)	EUS only (group B) (n = 56)	P-value1	ERCP only (group C) (n = 53)	P-value2
Demographics
Age (yr) (mean ± SD) (Range)	65.2 ± 15.6 (18-93)	63.4 ± 15.7 (19-85)	0.54	54.7 ± 21.3 (14-96)	0.004
Sex, male (%)	43%	66%	0.02	59%	0.12
Indications
Pancreatic mass	10 (19)	16 (29)	0.26	3 (6)	0.07
Cholangiocarcinoma	3 (6)	1 (2)	0.36	0 (0)	0.24
CBD stones	3 (6)	2 (4)	0.68	6 (11)	0.32
CBD stricture	1 (2)	10 (18)	0.01	1 (2)	1.00
Cholangitis	0	0	NA	8 (15)	NA
Abnormal imaging	10 (19)	10 (18)	1.00	2 (4)	0.03
Pancreatitis	4 (7)	4 (7)	1.00	1 (2)	0.36
Completion
Completion of procedures	EUS 54 (100)	56 (100)	1.00	46 (87)	0.56
	ERCP 49 (91)

¹P-value of group A vs group B;

²P-value of group A vs group C. EUS: Endoscopic ultrasound; ERCP: Endoscopic retrograde cholangiopancreatography; CBD: Common bile duct; NA: Not available.